1 year return (CAGR)
-10.19%
Chemomab Therapeutics Ltd DRC Exchange (NASDAQ, USD)
CMMB
2.38
-0.10 (-4.03%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-48.52%
5 year return (CAGR)
-58.90%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
17.44M
Price/Sales
-
Ent value
12.99M
Price/Book
2.01
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-39.04%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.46 |
| Daily high | 2.63 |
| Daily low | 2.36 |
| Daily Volume | 133K |
| All-time high | 38092.80 |
| 1y analyst estimate | 5.00 |
| Beta | 0.66 |
| EPS (TTM) | -0.95 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CMMB | S&P500 | |
| Current price drop from All-time high | -99.99% | -0.58% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 24 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -92.10% | -10.68% |
| Avg time to new high | 478 days | 12 days |
| Max time to new high | 1910 days | 1805 days |
News
